Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 115

1.

Retained organic solutes, patient characteristics and all-cause and cardiovascular mortality in hemodialysis: results from the retained organic solutes and clinical outcomes (ROSCO) investigators.

Melamed ML, Plantinga L, Shafi T, Parekh R, Meyer TW, Hostetter TH, Coresh J, Powe NR.

BMC Nephrol. 2013 Jun 27;14:134. doi: 10.1186/1471-2369-14-134.

2.

Free Levels of Selected Organic Solutes and Cardiovascular Morbidity and Mortality in Hemodialysis Patients: Results from the Retained Organic Solutes and Clinical Outcomes (ROSCO) Investigators.

Shafi T, Meyer TW, Hostetter TH, Melamed ML, Parekh RS, Hwang S, Banerjee T, Coresh J, Powe NR.

PLoS One. 2015 May 4;10(5):e0126048. doi: 10.1371/journal.pone.0126048. eCollection 2015.

3.

Results of the HEMO Study suggest that p-cresol sulfate and indoxyl sulfate are not associated with cardiovascular outcomes.

Shafi T, Sirich TL, Meyer TW, Hostetter TH, Plummer NS, Hwang S, Melamed ML, Banerjee T, Coresh J, Powe NR.

Kidney Int. 2017 Dec;92(6):1484-1492. doi: 10.1016/j.kint.2017.05.012. Epub 2017 Jul 21.

4.

Effect of increasing dietary fiber on plasma levels of colon-derived solutes in hemodialysis patients.

Sirich TL, Plummer NS, Gardner CD, Hostetter TH, Meyer TW.

Clin J Am Soc Nephrol. 2014 Sep 5;9(9):1603-10. doi: 10.2215/CJN.00490114. Epub 2014 Aug 21.

5.

Serum β-trace protein and risk of mortality in incident hemodialysis patients.

Shafi T, Parekh RS, Jaar BG, Plantinga LC, Oberai PC, Eckfeldt JH, Levey AS, Powe NR, Coresh J.

Clin J Am Soc Nephrol. 2012 Sep;7(9):1435-45. doi: 10.2215/CJN.02240312. Epub 2012 Jun 28.

6.

p-Cresyl sulfate and indoxyl sulfate in hemodialysis patients.

Meijers BK, De Loor H, Bammens B, Verbeke K, Vanrenterghem Y, Evenepoel P.

Clin J Am Soc Nephrol. 2009 Dec;4(12):1932-8. doi: 10.2215/CJN.02940509. Epub 2009 Oct 15.

7.

Association of indoxyl sulfate with heart failure among patients on hemodialysis.

Cao XS, Chen J, Zou JZ, Zhong YH, Teng J, Ji J, Chen ZW, Liu ZH, Shen B, Nie YX, Lv WL, Xiang FF, Tan X, Ding XQ.

Clin J Am Soc Nephrol. 2015 Jan 7;10(1):111-9. doi: 10.2215/CJN.04730514. Epub 2014 Oct 20.

8.

Meta-Analysis of the Associations of p-Cresyl Sulfate (PCS) and Indoxyl Sulfate (IS) with Cardiovascular Events and All-Cause Mortality in Patients with Chronic Renal Failure.

Lin CJ, Wu V, Wu PC, Wu CJ.

PLoS One. 2015 Jul 14;10(7):e0132589. doi: 10.1371/journal.pone.0132589. eCollection 2015. Review.

9.

Removal of the protein-bound solutes indican and p-cresol sulfate by peritoneal dialysis.

Pham NM, Recht NS, Hostetter TH, Meyer TW.

Clin J Am Soc Nephrol. 2008 Jan;3(1):85-90. Epub 2007 Nov 28.

10.

A plasma long-chain acylcarnitine predicts cardiovascular mortality in incident dialysis patients.

Kalim S, Clish CB, Wenger J, Elmariah S, Yeh RW, Deferio JJ, Pierce K, Deik A, Gerszten RE, Thadhani R, Rhee EP.

J Am Heart Assoc. 2013 Dec 5;2(6):e000542. doi: 10.1161/JAHA.113.000542.

11.

Effects of AST-120 on blood concentrations of protein-bound uremic toxins and biomarkers of cardiovascular risk in chronic dialysis patients.

Lee CT, Hsu CY, Tain YL, Ng HY, Cheng BC, Yang CC, Wu CH, Chiou TT, Lee YT, Liao SC.

Blood Purif. 2014;37(1):76-83. doi: 10.1159/000357641. Epub 2014 Feb 22.

PMID:
24576840
12.

Serum free p-cresyl sulfate levels predict cardiovascular and all-cause mortality in elderly hemodialysis patients--a prospective cohort study.

Wu IW, Hsu KH, Hsu HJ, Lee CC, Sun CY, Tsai CJ, Wu MS.

Nephrol Dial Transplant. 2012 Mar;27(3):1169-75. doi: 10.1093/ndt/gfr453. Epub 2011 Sep 2.

PMID:
21891772
13.

Colonic contribution to uremic solutes.

Aronov PA, Luo FJ, Plummer NS, Quan Z, Holmes S, Hostetter TH, Meyer TW.

J Am Soc Nephrol. 2011 Sep;22(9):1769-76. doi: 10.1681/ASN.2010121220. Epub 2011 Jul 22.

14.

Prominent accumulation in hemodialysis patients of solutes normally cleared by tubular secretion.

Sirich TL, Funk BA, Plummer NS, Hostetter TH, Meyer TW.

J Am Soc Nephrol. 2014 Mar;25(3):615-22. doi: 10.1681/ASN.2013060597. Epub 2013 Nov 14.

15.

Serum total p-cresol and indoxyl sulfate correlated with stage of chronic kidney disease in renal transplant recipients.

Huang ST, Shu KH, Cheng CH, Wu MJ, Yu TM, Chuang YW, Chen CH.

Transplant Proc. 2012 Apr;44(3):621-4. doi: 10.1016/j.transproceed.2011.11.023.

PMID:
22483453
16.

Free serum concentrations of the protein-bound retention solute p-cresol predict mortality in hemodialysis patients.

Bammens B, Evenepoel P, Keuleers H, Verbeke K, Vanrenterghem Y.

Kidney Int. 2006 Mar;69(6):1081-7.

17.

Free and total p-cresol sulfate levels and infectious hospitalizations in hemodialysis patients in CHOICE and HEMO.

Banerjee T, Meyer TW, Shafi T, Hostetter TH, Melamed M, Zhu Y, Powe NR.

Medicine (Baltimore). 2017 Feb;96(6):e5799. doi: 10.1097/MD.0000000000005799.

18.

Indoxyl-beta-D-glucuronide and 3-indoxyl sulfate in plasma of hemodialysis patients.

Agatsuma S, Sekino H, Watanabe H.

Clin Nephrol. 1996 Apr;45(4):250-6.

PMID:
8861801
19.

Functional genomic analysis identifies indoxyl sulfate as a major, poorly dialyzable uremic toxin in end-stage renal disease.

Jhawar S, Singh P, Torres D, Ramirez-Valle F, Kassem H, Banerjee T, Dolgalev I, Heguy A, Zavadil J, Lowenstein J.

PLoS One. 2015 Mar 26;10(3):e0118703. doi: 10.1371/journal.pone.0118703. eCollection 2015.

20.

Relationship of impaired olfactory function in ESRD to malnutrition and retained uremic molecules.

Raff AC, Lieu S, Melamed ML, Quan Z, Ponda M, Meyer TW, Hostetter TH.

Am J Kidney Dis. 2008 Jul;52(1):102-10. doi: 10.1053/j.ajkd.2008.02.301. Epub 2008 Apr 18.

Supplemental Content

Support Center